Key Points
-
Doppler ultrasonography is the first imaging technique to be used for portal vein thrombosis (PVT) diagnosis; it is well-tolerated, accurate and a negative examination performed by a trained operator is sufficient to rule out thrombosis
-
Following PVT diagnosis, imaging techniques should guide clinicians about the presence or absence of prothrombotic conditions such as cirrhosis, solid tumours and septic foci, and signs suggestive of malignant thrombosis
-
CT or MRI is needed to assess the number of vessels involved in thrombosis, the severity of thrombotic stenoses and to map collateral circulation, all of which have prognostic importance
-
Imaging should determine signs of chronicity to determine the age of the thrombus; existence of a portal vein remnant should also be investigated
-
Magnetic resonance cholangiography is the technique of choice to assess portal cholangiopathy in patients with PVT; grade 3 portal cholangiopathy is associated with an increased risk of biliary complications
-
Imaging should be repeated 3–6 months after the first diagnosis and every 6 months thereafter, to inform about thrombosis improvement, stability and progression; symptoms suggesting re-thrombosis should be reassessed by CT or MRI
Abstract
Thrombosis of the portal venous system is a frequent and potentially life-threatening condition that can take place in a number of different clinical settings including liver cirrhosis, hepatocellular carcinoma, other solid tumours, abdominal septic foci, acute pancreatitis, haematological malignancies and congenital or acquired prothrombotic disorders. Clinical decision-making in patients with thrombosis of the portal venous system is a particularly complex process owing to the heterogeneity of the population affected by this condition and the lack of high-quality evidence from randomized controlled trials for the use of anticoagulation therapy in these patients. This Review discusses the available data regarding how imaging can provide assistance to physicians involved in this decision-making process in different clinical settings. A flowchart illustrating how to use imaging in this setting, based on current evidence and on the experience of the Vascular Liver Diseases Group of the Hospital Clinic in Barcelona, is also presented.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yerdel, M. A. et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69, 1873–1881 (2000).
Rajani, R. et al. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment. Pharmacol. Ther. 32, 1154–1162 (2010).
Garcia-Pagan, J. C., Hernandez-Guerra, M. & Bosch, J. Extrahepatic portal vein thrombosis. Semin. Liver Dis. 28, 282–292 (2008).
Plessier, A. et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 51, 210–218 (2010).
Valla, D. et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology 94, 1063–1069 (1988).
Denninger, M. H. et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31, 587–591 (2000).
Primignani, M. et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 41, 603–608 (2007).
Turnes, J. et al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin. Gastroenterol. Hepatol 6, 1412–1417 (2008).
Nonami, T., Yokoyama, I., Iwatsuki, S. & Starzl, T. E. The incidence of portal vein thrombosis at liver transplantation. Hepatology 16, 1195–1198 (1992).
Tripodi, A., Anstee, Q. M., Sogaard, K. K., Primignani, M. & Valla, D. C. Hypercoagulability in cirrhosis: causes and consequences. J. Thromb. Haemost. 9, 1713–1723 (2011).
Tripodi, A. & Mannucci, P. M. The coagulopathy of chronic liver disease. N. Engl. J. Med. 365, 147–156 (2011).
Amitrano, L. et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J. Hepatol. 40, 736–741 (2004).
Francoz, C. et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 54, 691–697 (2005).
Englesbe, M. J. et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl. 16, 83–90 (2010).
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 56, 908–943 (2012).
Delgado, M. G. et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin. Gastroenterol. Hepatol. 10, 776–783 (2012).
Tessler, F. N. et al. Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am. J. Roentgenol. 157, 293–296 (1991).
Bach, A. M. et al. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 201, 149–154 (1996).
Chawla, Y. & Kumar, S. Portal venous flow in Budd-Chiari syndrome [letter]. Indian J. Gastroenterol. 17, 37 (1998).
Gertsch, P., Matthews, J., Lerut, J., Luder, P. & Blumgart, L. H. Acute thrombosis of the splanchnic veins. Arch. Surg. 128, 341–345 (1993).
Berzigotti, A., Zoli, M., Bru, C. & Gilabert, R. in Portal Hypertension V: Proceedings of the Fifth Baveno International Consensus Workshop (ed. de Franchis, R.) 28–36 (Wiley Blackwell, 2010).
Berzigotti, A. & Piscaglia, F. Ultrasound in portal hypertension—part 2—and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall. Med. 33, 8–32 (2012).
Grant, E. G., Tessler, F. N. & Perrella, R. R. Clinical Doppler imaging. AJR Am. J. Roentgenol. 152, 707–717 (1989).
Claudon, M. et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall. Med. 34, 11–29 (2013).
Rossi, S. et al. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR Am. J. Roentgenol. 186, 763–773 (2006).
Sabba, C. et al. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 21, 428–433 (1995).
Kuszyk, B. S. et al. Portal venous system thrombosis: helical CT angiography before transjugular intrahepatic portosystemic shunt creation. Radiology 206, 179–186 (1998).
Mori, H. et al. High-attenuation recent thrombus of the portal vein: CT demonstration and clinical significance. Radiology 163, 353–356 (1987).
DeLeve, L. D., Valla, D. C. & Garcia-Tsao, G. Vascular disorders of the liver. Hepatology 49, 1729–1764 (2009).
Sodickson, A. et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology 251, 175–184 (2009).
American College of Radiology. Manual on Contrast Media version 8, 33–42 (2012).
Shimada, K. et al. Non-contrast-enhanced MR portography with time-spatial labeling inversion pulses: comparison of imaging with three-dimensional half-fourier fast spin-echo and true steady-state free-precession sequences. J. Magn. Reson. Imaging 29, 1140–1146 (2009).
Berzigotti, A. et al. Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis. J. Hepatol. 52, 846–853 (2010).
Colli, A. et al. Severe liver fibrosis or cirrhosis: accuracy of US for detection—analysis of 300 cases. Radiology 227, 89–94 (2003).
Vilgrain, V. et al. Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation. Radiology 241, 149–155 (2006).
Hillaire, S. et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 51, 275–280 (2002).
Seijo, S. et al. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension. Dig. Liver Dis. 44, 855–860 (2012).
Sharma, P., Mishra, S. R., Kumar, M., Sharma, B. C. & Sarin, S. K. Liver and spleen stiffness in patients with extrahepatic portal vein obstruction. Radiology 263, 893–899 (2012).
Friedrich-Rust, M. et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 252, 595–604 (2009).
Ferraioli, G. et al. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology 56, 2125–2133 (2012).
Harris, S., Nadkarni, N. A., Naina, H. V. & Vege, S. S. Splanchnic vein thrombosis in acute pancreatitis: a single-center experience. Pancreas 42, 1251–1254 (2013).
Calvet, X. et al. Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. J. Hepatol. 10, 311–317 (1990).
Stuart, K. E., Anand, A. J. & Jenkins, R. L. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 77, 2217–2222 (1996).
Rossi, S. et al. Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma. Eur. Radiol. 18, 1749–1756 (2008).
Raab, B. W. The thread and streak sign. Radiology 236, 284–285 (2005).
Catalano, O. A., Choy, G., Zhu, A., Hahn, P. F. & Sahani, D. V. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 254, 154–162 (2010).
Qian, L. J. et al. Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study. Eur. Radiol. 22, 2178–2185 (2012).
Piscaglia, F. et al. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. Liver Transpl. 16, 658–667 (2010).
de Ville de Goyet, J. et al. Direct bypassing of extrahepatic portal venous obstruction in children: a new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension. J. Pediatr. Surg. 33, 597–601 (1998).
Hanbidge, A. E., Lynch, D. & Wilson, S. R. US of the peritoneum. Radiographics 23, 663–684 (2003).
de Ville de Goyet, J. et al. Meso-Rex bypass as an alternative technique for portal vein reconstruction at or after liver transplantation in children: review and perspectives. Pediatr. Transplant. 17, 19–26 (2013).
Chaves, I. J. et al. Pre- and postoperative imaging and interventions for the meso-Rex bypass in children and young adults. Pediatr. Radiol. 42, 220–232 (2012).
Cakmak, O. et al. Role of contrast-enhanced 3D magnetic resonance portography in evaluating portal venous system compared with color Doppler ultrasonography. Abdom. Imaging 33, 65–71 (2008).
Seeger, M. et al. Chronic portal vein thrombosis: transcapsular hepatic collateral vessels and communicating ectopic varices. Radiology 257, 568–578 (2010).
Miyamoto, A. et al. Living-related liver transplantation with renoportal anastomosis for a patient with large spontaneous splenorenal collateral. Transplantation 75, 1596–1598 (2003).
Brancatelli, G., Federle, M. P., Pealer, K. & Geller, D. A. Portal venous thrombosis or sclerosis in liver transplantation candidates: preoperative CT findings and correlation with surgical procedure. Radiology 220, 321–328 (2001).
Luca, A. et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 60, 846–852 (2011).
Dhiman, R. K., Behera, A., Chawla, Y. K., Dilawari, J. B. & Suri, S. Portal hypertensive biliopathy. Gut 56, 1001–1008 (2007).
Condat, B. et al. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology 37, 1302–1308 (2003).
Llop, E. et al. Portal cholangiopathy: radiological classification and natural history. Gut 60, 853–860 (2011).
Galati, G. et al. A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation. Eur. J. Gastroenterol. Hepatol. 21, 233–236 (2009).
Plessier, A., Rautou, P. E. & Valla, D. C. Management of hepatic vascular diseases. J. Hepatol. 56 (Suppl. 1), S25–S38 (2012).
Spaander, M. C. et al. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J. Thromb. Haemost. 11, 452–459 (2013).
Francoz, C., Valla, D. & Durand, F. Portal vein thrombosis, cirrhosis, and liver transplantation. J. Hepatol. 57, 203–212 (2012).
Luca, A. et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology 265, 124–132 (2012).
Maruyama, H. et al. Prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: a novel approach with contrast-enhanced ultrasound. Abdom. Imaging 37, 431–438 (2012).
Brenner, D. J. & Hall, E. J. Computed tomography—an increasing source of radiation exposure. N. Engl. J. Med. 357, 2277–2284 (2007).
Reiter, T. et al. Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 14, 31 (2012).
Berzigotti, A., Piscaglia, F. & EFSUMB Education and Professional Standard Committee. Clinical recommendations for the performance and reporting of ultrasound examination for portal hypertension European Federation of Societies for Ultrasound in Medicine and Biology [online], (2011).
Acknowledgements
The authors are members of the Vascular Liver Diseases Group of the Hospital Clinic in Barcelona, and would like to express their gratitude to all the colleagues (clinicians, radiologists, anaesthesiologists and surgeons) that participate in the work of this multidisciplinary team. The authors thank the nursing and technical staff of the Hepatic Hemodynamic Laboratory and of the CDIC, and Ms C. Esteva for expert secretarial support. CIBERehd is funded by the Instituto de Salud Carlos III.
Author information
Authors and Affiliations
Contributions
A. Berzigotti contributed to all aspects in the generation of this article. Á. García-Criado and A. Darnell contributed equally to researching data for the article, discussion of content and reviewing/editing the manuscript before submission. J.-C. García-Pagán substantially contributed to the discussion of content and reviewed/edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Berzigotti, A., García-Criado, Á., Darnell, A. et al. Imaging in clinical decision-making for portal vein thrombosis. Nat Rev Gastroenterol Hepatol 11, 308–316 (2014). https://doi.org/10.1038/nrgastro.2013.258
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2013.258
This article is cited by
-
Triglyceride to HDL-C ratio is associated with plasma D-dimer levels in different types of pancreatitis
Scientific Reports (2022)
-
Differentiation of malignant from non-malignant portal vein thrombosis in liver cirrhosis: the challenging dilemma
Egyptian Liver Journal (2021)
-
Role of imaging in visceral vascular emergencies
Insights into Imaging (2020)
-
Tumor in the veins: an abdominal perspective with an emphasis on CT and MR imaging
Insights into Imaging (2020)
-
Serum D-dimer levels at admission for prediction of outcomes in acute pancreatitis
BMC Gastroenterology (2019)